ATE221778T1 - Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung - Google Patents

Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung

Info

Publication number
ATE221778T1
ATE221778T1 AT95920874T AT95920874T ATE221778T1 AT E221778 T1 ATE221778 T1 AT E221778T1 AT 95920874 T AT95920874 T AT 95920874T AT 95920874 T AT95920874 T AT 95920874T AT E221778 T1 ATE221778 T1 AT E221778T1
Authority
AT
Austria
Prior art keywords
via inhalation
insuflation
compositions
compounds
administration via
Prior art date
Application number
AT95920874T
Other languages
English (en)
Inventor
Constantin Efthymiopoulos
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Application granted granted Critical
Publication of ATE221778T1 publication Critical patent/ATE221778T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95920874T 1994-05-28 1995-05-24 Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung ATE221778T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9410817A GB9410817D0 (en) 1994-05-28 1994-05-28 Medicaments
PCT/EP1995/001967 WO1995032712A1 (en) 1994-05-28 1995-05-24 Compounds and compositions for administration via oral inhalation or insufflation

Publications (1)

Publication Number Publication Date
ATE221778T1 true ATE221778T1 (de) 2002-08-15

Family

ID=10755922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920874T ATE221778T1 (de) 1994-05-28 1995-05-24 Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung

Country Status (12)

Country Link
EP (1) EP0764023B1 (de)
JP (1) JPH10500966A (de)
AT (1) ATE221778T1 (de)
AU (1) AU701590B2 (de)
DE (1) DE69527713T2 (de)
DK (1) DK0764023T3 (de)
ES (1) ES2176330T3 (de)
GB (1) GB9410817D0 (de)
IL (1) IL113879A (de)
PT (1) PT764023E (de)
WO (1) WO1995032712A1 (de)
ZA (1) ZA954331B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100409844C (zh) 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
KR20000068986A (ko) 1996-11-14 2000-11-25 리차드웨드레이 신규 용도 화합물 및 그 제조방법
WO1998031817A2 (en) * 1997-01-14 1998-07-23 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CN103260615A (zh) * 2010-09-27 2013-08-21 希普拉有限公司 包含扎那米韦的低剂量药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01287029A (ja) * 1988-05-13 1989-11-17 Mect Corp 新規抗ウィルス剤
SK282950B6 (sk) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid

Also Published As

Publication number Publication date
PT764023E (pt) 2002-12-31
IL113879A0 (en) 1995-08-31
ZA954331B (en) 1996-01-29
JPH10500966A (ja) 1998-01-27
IL113879A (en) 2001-01-11
AU701590B2 (en) 1999-02-04
GB9410817D0 (en) 1994-07-20
EP0764023A1 (de) 1997-03-26
WO1995032712A1 (en) 1995-12-07
DE69527713T2 (de) 2003-04-10
AU2615795A (en) 1995-12-21
DK0764023T3 (da) 2002-11-18
DE69527713D1 (de) 2002-09-12
EP0764023B1 (de) 2002-08-07
ES2176330T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
ATE241334T1 (de) Mittel zur förderung des haarwachstums
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE19975040I2 (de) Medikamente enthaltend Salmeterol und Fluticason
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
FI953814A7 (fi) Menetelmät progressiivisen kudoskuolion, bakteerien translokaation, re perfuusiovaurion ja hengityksen vajaatoiminnan estämiseksi
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
DE69527713D1 (de) Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
DE69322251D1 (de) Medizinische zusammensetzung
DE69414354D1 (de) Polyzyklische aromatische Verbindungen, sie enthaltende pharmazeutische und kosmetische Zusammensetzungen und deren Verwendungen
HU9400685D0 (en) Veterinary composition of anesthetic activity
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
AU653861B2 (en) Respiratory disease vaccine for cats
DE69327693D1 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
SI1011664T1 (en) 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DK0659341T3 (da) Fast insecticidt præparat
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
ATE49101T1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.
IT8419846A0 (it) Composizione di presidi per la disinfezione e la sterilizzazione ambientale, in particolare strumenti chirurgici, endoscopici, dentistici e per anestesia.